Entera Bio (ENTX) Return on Equity (2021 - 2026)

Entera Bio has disclosed Return on Equity across 6 years of filings, most recently posting 0.01% for Q1 2026.

• Quarterly Return on Equity changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Equity retreated to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• Over five years, Return on Equity peaked at 0.01% in Q2 2025 and troughed at 0.01% in Q3 2023.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Equity.
• Annual changes were most pronounced in 2022 — Return on Equity slipped 1 bps — and 2025, when it gained 1 bps.
• Tracing ENTX's Return on Equity over 5 years: stood at 0.01% in 2022, then slipped by 7 bps to 0.01% in 2023, then declined by 24 bps to 0.01% in 2024, then jumped by 38 bps to 0.01% in 2025, then retreated by 29 bps to 0.01% in 2026.
• Business Quant data shows ENTX's Return on Equity at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.